Travere’s launchpad positions Filspari for fast rise toward blockbuster sales: analyst
24th April 2026 Uncategorised 0An established sales force and payer authorization criteria will fuel a fast launch for Travere Therapeutics’ Filspari in its new indication and power the franchise to peak sales of $3.1 billion, Guggenheim Securities analysts predicted in a note to investors.
More: Travere’s launchpad positions Filspari for fast rise toward blockbuster sales: analyst
Source: fierce